Atomoxetine Hydrochloride Capsules Market Overview

added blog Health

2026-07-08 09:56:15 -

The Atomoxetine Hydrochloride Capsules Market was valued at USD 1,600 million in 2024 and is projected to reach USD 3,500 million by 2035, growing at a robust CAGR of 7.5%. Atomoxetine hydrochloride is a non-stimulant medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. Unlike traditional stimulant medications, atomoxetine works by...

0 Comments 0 Shares 69 Views 0 Reviews